Impax Asset Management Group plc Has $7.76 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Impax Asset Management Group plc trimmed its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 47,779 shares of the company's stock after selling 2,706 shares during the quarter. Impax Asset Management Group plc's holdings in Clorox were worth $7,760,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CLX. Catalyst Capital Advisors LLC acquired a new stake in shares of Clorox during the 3rd quarter worth $54,000. Los Angeles Capital Management LLC grew its stake in Clorox by 5.6% during the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock worth $31,266,000 after buying an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock valued at $4,865,000 after buying an additional 9,037 shares during the period. Natixis Advisors LLC increased its holdings in Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock valued at $10,341,000 after buying an additional 4,839 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Clorox by 1.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock valued at $117,932,000 after buying an additional 13,038 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Trading Up 1.4 %

NYSE:CLX traded up $2.14 during trading hours on Friday, hitting $156.52. 1,498,518 shares of the company were exchanged, compared to its average volume of 1,378,293. The company has a fifty day simple moving average of $157.04 and a 200 day simple moving average of $160.05. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The stock has a market capitalization of $19.28 billion, a price-to-earnings ratio of 42.76, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the company earned $2.16 EPS. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio is presently 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent analyst reports. Barclays lifted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. Evercore ISI boosted their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. JPMorgan Chase & Co. raised their price target on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.